fda stance on compounded semaglutide The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new (Wegovy) weight-loss pill from the FDA says 'no clinical need'

You know, you take a drug like ozempic, its extremely expensive

This is much more robust weight loss than Wevogy or Zepbound, says Jody Dushay, MD, an assistant professor at Harvard Medical School and an endocrinologist at Beth Israel Deaconess Medical Center in Boston, who was not involved in the study

For semaglutide users, the steady-state approach to electrolyte supplementation works well

Kelley D., a mom of two in Indiana, used a GLP-1 to help her lose weight (though not in the immediate postpartum period), and while it made a positive impact on her, it wasnt always pleasant

Without medical supervision, adverse effects cannot be appropriately monitored or managed

But what if there was a tool that could work with your body to help you achieve your goals